Skip to main content
Premium Trial:

Request an Annual Quote

Motorola Life Sciences Exec Joins Zyomyx as Chief Business Officer

NEW YORK, Sept. 18 – Nicolas Naclerio, the founder of Motorola’s life sciences division and former general manager of its BioChip Systems unit, has joined protein chip maker Zyomyx as its senior vice president and chief business officer, Zyomyx said Tuesday.

In his new role Naclerio will be in charge of corporate development, sales, and marketing for Zyomyx of Hayward, Calif. He will also be responsible for launching the company’s new products and services.

"As founder of Motorola's life sciences division and vice president of their BioChip Systems group, Nick truly pioneered what has become an important genomic technology," Larry Cohen, CEO of Zyomyx, said in a statement.

"His breadth of experience in business development, as well as his superb team building and leadership skills, make Nick the right person for this position,” Cohen said.

Naclerio could not immediately be reached for comment regarding the circumstances of his departure from Motorola.

During his tenure with the communications giant, Naclerio developed the company’s life science strategy and launched its products for gene expression profiling and SNP scoring. He holds a PhD in electrical engineering.

It could not immediately be determined if Motorola had replaced Naclerio.

Zyomyx is currently developing chips designed to detect up to 10,000 different proteins. The company has previously signed deals with Cambridge Antibody Technology and Dyax for access to their antibody resources and technologies and has said that it planned to begin beta testing its chips in the first half of 2001.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.